Anthony A. Meluch
About
Anthony A. Meluch is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery.
According to data from OpenAlex, Anthony A. Meluch has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 18 papers in Oncology and 15 papers in Surgery. Recurrent topics in Anthony A. Meluch's work include Cancer Treatment and Pharmacology (9 papers), Esophageal Cancer Research and Treatment (9 papers) and Prostate Cancer Treatment and Research (9 papers). Anthony A. Meluch is often cited by papers focused on Cancer Treatment and Pharmacology (9 papers), Esophageal Cancer Research and Treatment (9 papers) and Prostate Cancer Treatment and Research (9 papers). Anthony A. Meluch collaborates with scholars based in United States, United Kingdom and Canada. Anthony A. Meluch's co-authors include John D. Hainsworth, F. Anthony Greco, Howard A. Burris, Lisa H. Morrissey, David R. Spigel, Kathleen J. Yost, Ronald G. Steis, David Waterhouse, Timothy J. O’Rourke and James R. Gray and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Molecular and Cellular Biology.
In The Last Decade
Anthony A. Meluch
43 papers receiving 1.1k citations
Peers
Anthony A. Meluch
Claudio Dazzi Italy
L.L. Siu Canada
Preston D. Steen United States
Yuanhong Gao China
Daniel Rauch Switzerland
David Gibbons Ireland
Daiki Masuya Japan
Teodoro Sava Italy
Suk Joong Oh South Korea
Koji Enomoto Japan
Citations per year, relative to Anthony A. Meluch Anthony A. Meluch (= 1×)
peers
Claudio Dazzi
Countries citing papers authored by Anthony A. Meluch
Since
Specialization
Citations
This map shows the geographic impact of Anthony A. Meluch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony A. Meluch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony A. Meluch more than expected).
Fields of papers citing papers by Anthony A. Meluch
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Anthony A. Meluch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony A. Meluch. The network helps show where Anthony A. Meluch may publish in the future.
Co-authorship network of co-authors of Anthony A. Meluch
This figure shows the co-authorship network connecting the top 25 collaborators of Anthony A. Meluch. A scholar is included among the top collaborators of Anthony A. Meluch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony A. Meluch. Anthony A. Meluch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Meluch, Anthony A., Dianna Shipley, David Waterhouse, et al.. (2011). High-dose bevacizumab in the treatment of patients with advanced clear cell renal carcinoma (RCC): A Sarah Cannon Research Institute phase II trial.. Journal of Clinical Oncology. 29(15_suppl). e15101–e15101.
2.
Hainsworth, John D., David R. Spigel, F. Anthony Greco, et al.. (2011). Combined Modality Treatment With Chemotherapy, Radiation Therapy, Bevacizumab, and Erlotinib in Patients With Locally Advanced Squamous Carcinoma of the Head and Neck. The Cancer Journal. 17(5). 267–272.
3.
Burris, Howard A., Suzanne F. Jones, Dianna Shipley, et al.. (2010). Phase II Study of Capecitabine in Combination With Thalidomide in Patients With Metastatic Breast Cancer. Cancer Investigation. 28(4). 408–412.
4.
Spigel, David R., F. Anthony Greco, Anthony A. Meluch, et al.. (2010). Phase I/II Trial of Preoperative Oxaliplatin, Docetaxel, and Capecitabine With Concurrent Radiation Therapy in Localized Carcinoma of the Esophagus or Gastroesophageal Junction. Journal of Clinical Oncology. 28(13). 2213–2219.
5.
Meluch, Anthony A., H.A. Burris, Cassie M. Lane, et al.. (2009). Combined modality therapy with radiation therapy (RT), chemotherapy, bevacizumab, and erlotinib in the treatment of patients (pts) with locally advanced squamous carcinoma of the head and neck. Journal of Clinical Oncology. 27(15_suppl). 6012–6012.
6.
Hainsworth, John D., Anthony A. Meluch, Cassie M. Lane, et al.. (2009). Single Agent Vinflunine in the Salvage Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Trial of the Sarah Cannon Research Consortium. Cancer Investigation. 28(3). 275–279.
7.
Hainsworth, John D., Anthony A. Meluch, David R. Spigel, et al.. (2007). Weekly Docetaxel and Bortezomib as First-Line Treatment for Patients with Hormone-Refractory Prostate Cancer: A Minnie Pearl Cancer Research Network Phase II Trial. Clinical Genitourinary Cancer. 5(4). 278–283.
8.
Hainsworth, John D., et al.. (2006). Weekly Docetaxel/Estramustine Phosphate in Patients with Increasing Serum Prostate-Specific Antigen Levels After Primary Treatment for Prostate Cancer: A Phase II Trial of the Minnie Pearl Cancer Research Network. Clinical Genitourinary Cancer. 4(4). 287–292.
9.
Hainsworth, John D., Denise A. Yardley, David R. Spigel, et al.. (2006). Docetaxel and Epirubicin as First-Line Treatment for Patients with Metastatic Breast Cancer: A Minnie Pearl Cancer Research Network Phase II Trial. Cancer Investigation. 24(5). 469–473.
10.
Mathew, Paul, Peter F. Thall, Melissa M. Johnson, et al.. (2006). Preliminary results of a randomized placebo-controlled double-blind trial of weekly docetaxel combined with imatinib in men with metastatic androgen-independent prostate cancer (AIPC) and bone metastases (BM). Journal of Clinical Oncology. 24(18_suppl). 4562–4562.
11.
Hainsworth, John D., Anthony A. Meluch, Sharlene Litchy, et al.. (2005). Paclitaxel, carboplatin, and gemcitabine in the treatment of patients with advanced transitional cell carcinoma of the urothelium. Cancer. 103(11). 2298–2303.
12.
Gray, J. R., John D. Hainsworth, Anthony A. Meluch, et al.. (2005). Concurrent paclitaxel/carboplatin/infusional 5-FU/radiation therapy (RT) with or without subsequent esophageal resection in patients with localized esophageal cancer: A Minnie Pearl Cancer Research Network trial. Journal of Clinical Oncology. 23(16_suppl). 4018–4018.
13.
Meluch, Anthony A., F. Anthony Greco, Lisa H. Morrissey, et al.. (2003). Weekly paclitaxel, estramustine phosphate, and oral etoposide in the treatment of hormone‐refractory prostate carcinoma. Cancer. 98(10). 2192–2198.
14.
Meluch, Anthony A., F. Anthony Greco, James R. Gray, et al.. (2003). Preoperative Therapy with Concurrent Paclitaxel/Carboplatin/Infusional 5-FU and Radiation Therapy in Locoregional Esophageal Cancer. The Cancer Journal. 9(4). 251–260.
15.
Hainsworth, John D., Anthony A. Meluch, James R. Gray, et al.. (2002). Induction Paclitaxel, Carboplatin, and Infusional 5-FU Followed by Concurrent Radiation Therapy and Weekly Paclitaxel/Carboplatin in the Treatment of Locally Advanced Head and Neck Cancer. The Cancer Journal. 8(4). 311–321.
16.
Hainsworth, John D., et al.. (2001). Paclitaxel, carboplatin, and long-term continuous infusion of 5-fluorouracil in the treatment of advanced squamous and other selected carcinomas. Cancer. 92(3). 642–649.
17.
Meluch, Anthony A., F. Anthony Greco, Howard A. Burris, et al.. (2001). Paclitaxel and Gemcitabine Chemotherapy for Advanced Transitional-Cell Carcinoma of the Urothelial Tract: A Phase II Trial of the Minnie Pearl Cancer Research Network. Journal of Clinical Oncology. 19(12). 3018–3024.
18.
Meluch, Anthony A., et al.. (2000). Gemcitabine and paclitaxel combination therapy in transitional cell carcinoma of the urothelium. European Journal of Cancer. 36. 30–33.
19.
Hainsworth, John D., Howard A. Burris, Joan B. Erland, et al.. (1999). Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinoma. Cancer. 85(6). 1269–1276.
20.
Meluch, Anthony A., John D. Hainsworth, J. R. Gray, et al.. (1999). Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network phase II trial.. PubMed. 5(2). 84–91.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Claudio Dazzi Breakdown of academic impact, for papers by L.L. Siu Breakdown of academic impact, for papers by Preston D. Steen Breakdown of academic impact, for papers by Yuanhong Gao Breakdown of academic impact, for papers by Daniel Rauch Breakdown of academic impact, for papers by David Gibbons Breakdown of academic impact, for papers by Daiki Masuya Breakdown of academic impact, for papers by Teodoro Sava Breakdown of academic impact, for papers by Suk Joong Oh Breakdown of academic impact, for papers by Koji Enomoto